[Degradation of diuron by persulfate oxidation activated by EDTA-ferrous ion in aqueous system].

Huan Jing Ke Xue

State Key Laboratory of Pollution Control and Resource Reuse, School of the Environment, Nanjing University, Nanjing 210093, China.

Published: May 2008

The method of diuron [3-(3,4-dichlorophenyl)-1, 1-dimethylurea] degradation by persulfate oxidation activated by EDTA-ferrous ion in aqueous system was conducted. Based on both of the degradation performance and the operating costs, optimal reaction condition was proposed. Operating at K2S2O8 initial concentration 2.0 mmol x L(-1), Fe(II) initial concentration 1.0 mmol x L(-1), EDTA initial concentration 0.5 mmol x L(-1), reaction time 300 min and pH = 7.0, about 67.6% of 0.1 mmol x L(1) diuron was degradation. Hydroxyl radicals and sulfate radicals produced in the system were determined by molecular probes (ethanol and tert-butanol) methods. The degradation products of diuron were identified with LC/MS methods and the degradation pathways of diuron were discussed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

initial concentration
12
concentration mmol
12
mmol l-1
12
persulfate oxidation
8
oxidation activated
8
activated edta-ferrous
8
edta-ferrous ion
8
ion aqueous
8
methods degradation
8
degradation
5

Similar Publications

Introduction: Therapeutic drug monitoring (TDM) in inflammatory rheumatic diseases (RMDs) is gaining interest. However, there are unresolved questions about the best practices for implementing TDM effectively in clinical settings.

Objective: The primary objective of this study was to evaluate whether early TDM of adalimumab predicts drug survival at 52 weeks in patients with RMDs.

View Article and Find Full Text PDF

Background: Healthcare resources have been concentrated in urban areas, leaving rural regions vulnerable to poorer health outcomes. The Problem Solving for Better Health (PSBH) program was implemented to enhance healthcare systems in resource-limited regions by training personnel to maximize existing resources in problem-solving. This study evaluated the implementation effectiveness of PSBH-Nursing (PSBHN), a nationally led initiative to train nurses in PSBH in Lesotho.

View Article and Find Full Text PDF

Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies.

Pharm Res

January 2025

BioDev Department WuXi Biologics USA, 1 Cedarbrook Dr, Cranbury, NJ, 08512, USA.

Background: High concentration protein formulation (HCPF) development needs to balance protein stability attributes such as conformational/colloidal stability, chemical stability, and solution properties such as viscosity and osmolality.

Methodology: A three-phase design is established in this work. In Phase 1, conformational and colloidal stability are measured by 384-well-based high-throughput (HT) biophysical screening while viscosity reduction screening is performed with HT viscosity screening.

View Article and Find Full Text PDF

Clinical trials demonstrate the short-term efficacy of dual CFTR modulators, but long-term real-world data is limited. We aimed to investigate the effects of 24-month lumacaftor/ivacaftor (LUM/IVA) therapy in pediatric CF patients (pwCF). This observational study included pwCF homozygous for F508del mutation treated between 2021 and 2023.

View Article and Find Full Text PDF

The present study was aimed at revealing the metabolic changes that occurred in the cellular lipid pattern of acute and chronic myeloid leukaemia cells following treatment with cannabidiol (CBD). CBD is a non-psychoactive compound present in Cannabis sativa L., which has shown an antiproliferative action in these type of cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!